Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

Obesity pipeline

What is next, and who is running it?

The next dated milestone on each program. A hollow marker is a registry primary completion date, not a company readout.

Include Phase 1
ClassNone selected
MechanismNone selected

83 of 94 programs on this timeline

202520262027202820292030Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Today

Abbott 1

No dated milestone in 2025 to 2030

AbbVie 1

ABBV-295Phase 2
No dated milestone in 2025 to 2030

Aconcagua Bio, Inc 1

ACCG-2671Phase 1/2
No dated milestone in 2025 to 2030

Altimmune 1

No dated milestone in 2025 to 2030

Amgen 1

No dated milestone in 2025 to 2030

Arrowhead 1

ARO-ALK7Phase 1/2
No dated milestone in 2025 to 2030

Ascletis Pharma (China) Co 1

ASC30Phase 3
No dated milestone in 2025 to 2030

AstraZeneca 4

No dated milestone in 2025 to 2030
ExenatidePhase 3
No dated milestone in 2025 to 2030
PramlintidePhase 2/3
No dated milestone in 2025 to 2030
AZD6234Phase 3
No dated milestone in 2025 to 2030

Biohaven Therapeutics 1

No dated milestone in 2025 to 2030

Boehringer Ingelheim 1

No dated milestone in 2025 to 2030

BrightGene Bio-Medical Technology Co 1

BGM0504Phase 3
No dated milestone in 2025 to 2030

Carmot Therapeutics, Inc 1

CT-868Phase 2
No dated milestone in 2025 to 2030

Company n/r 3

BeinaglutideStage n/r
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
LoxenatidePhase 2/3
No dated milestone in 2025 to 2030

CSPC Baike (Shandong) Biopharmaceutical Co 1

TG103Phase 3
No dated milestone in 2025 to 2030

Eli Lilly 7

TirzepatideApproved
No dated milestone in 2025 to 2030
OrforglipronApproved
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
LY4086940Phase 2
No dated milestone in 2025 to 2030
BimagrumabPhase 2
No dated milestone in 2025 to 2030

Empros Pharma AB 1

OrlistatApproved
No dated milestone in 2025 to 2030

Fujian Shengdi Pharmaceutical Co 1

RibupatidePhase 3
No dated milestone in 2025 to 2030

Gan & Lee Pharmaceuticals 1

No dated milestone in 2025 to 2030

Gasherbrum Bio, Inc 1

No dated milestone in 2025 to 2030

GSK 1

No dated milestone in 2025 to 2030

Guangdong Raynovent Biotech Co 1

RAY1225Phase 3
No dated milestone in 2025 to 2030

Hangzhou Sciwind Biosciences Co 1

No dated milestone in 2025 to 2030

Hengrui 1

No dated milestone in 2025 to 2030

Huadong Medicine 3

HDM1002Phase 3
No dated milestone in 2025 to 2030
HDM1702Phase 3
No dated milestone in 2025 to 2030
HDM1005Phase 3
No dated milestone in 2025 to 2030

Innovent 1

MazdutidePhase 3
No dated milestone in 2025 to 2030

Inversago Pharma 1

No dated milestone in 2025 to 2030

MindRank AI Ltd 1

MDR-001Phase 3
No dated milestone in 2025 to 2030

NeuroSearch 1

No dated milestone in 2025 to 2030

Novo Nordisk 9

SemaglutideApproved
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
LiraglutideApproved
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
LorcaserinPhase 1/2
No dated milestone in 2025 to 2030

Orexigen Therapeutics, Inc 1

No dated milestone in 2025 to 2030

PegBio Co 1

No dated milestone in 2025 to 2030

Pfizer 4

No dated milestone in 2025 to 2030
MET-233IPhase 1/2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

Regeneron 3

HS-20094Phase 3
No dated milestone in 2025 to 2030
GaretosmabPhase 2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

Rhythm 2

No dated milestone in 2025 to 2030
LB54640Phase 2
No dated milestone in 2025 to 2030

Roche 3

No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
CT-388Phase 3
No dated milestone in 2025 to 2030

Sanofi 3

No dated milestone in 2025 to 2030
RimonabantPhase 3
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

Scholar Rock 1

No dated milestone in 2025 to 2030

Shandong Suncadia Medicine Co 1

No dated milestone in 2025 to 2030

Shanghai Yinnuo Pharmaceutical Technology Co 1

No dated milestone in 2025 to 2030

Shanghai Yinnuo Pharmaceutical Technology Co. 1

SupaglutidePhase 2/3
No dated milestone in 2025 to 2030

Shionogi 1

VelneperitPhase 2
No dated milestone in 2025 to 2030

Skye Bioscience 1

NimacimabPhase 2
No dated milestone in 2025 to 2030

Terns, Inc 1

TERN-601Phase 2
No dated milestone in 2025 to 2030

The United Bio-Technology (Hengqin) Co 1

UBT251Phase 3
No dated milestone in 2025 to 2030

Verdiva Bio Dev Limited 1

VRB-101Phase 2
No dated milestone in 2025 to 2030

Veru Inc 1

EnobosarmPhase 2
No dated milestone in 2025 to 2030

Viking Therapeutics 2

VK2735Phase 3
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

Vincentage Pharma Co 1

VCT220Phase 3
No dated milestone in 2025 to 2030

VIVUS 1

No dated milestone in 2025 to 2030

Zafgen 1

BeloranibPhase 3
No dated milestone in 2025 to 2030

Zealand Pharma 1

No dated milestone in 2025 to 2030